KYIV. Dec 12 (Interfax-Ukraine) – JSC Lekhim pharmaceutical company (Kyiv) together with a group of persons on the basis of an agreement on coordination of actions for redemption of shares in CJSC Technolog pharmaceutical plant (Uman, Cherkasy region) plans to buy back the remaining shares of the enterprise.
According to a report on the website, Lekhim together with a group of individuals, owning the dominant controlling interest (98.89%) of Technolog, are planning to buy out the remaining 2.627 million shares, which is 1.11% of their total number.
Lekhim heads a group of companies, which, in addition to CJSC Technolog, includes PJSC Lekhim-Kharkiv.
At present, the product portfolio of Lekhim includes more than 160 trade names, in particular, medicines for treatment of digestive, cardiovascular, respiratory, nervous systems, blood and hemopoiesis systems, musculoskeletal system, antimicrobial, dermatological agents, as well as biologically active additives, medical products, veterinary drugs.
In October 2017 Technolog pharmaceutical factory on the results of the inspection received the European certificate GMP (Good Manufacturing Practice).
